Metabolic syndrome

Running head: METABOLIC SYNDROME Metabolic Syndrome James Doucette College of Western Idaho Abstract Metabolic syndrome is an emerging diagnosis in the medical field that has effects on patient care. Becoming familiar with it and having it become a common part of patient care will, if used appropriately will increase the lives of those who have become affected with or are at risk of becoming diagnosed with metabolic syndrome. Metabolic syndrome is a constellation of risks

Is Withaferin A, a magic bullet for metabolic syndrome? A recent and exciting new study shows that withaferin A, a steroidal lactone isolated from Withania somnifera plant, which is very commonly known as Ashwagandha or Indian ginseng or Indian winter cherry, can exert profound therapeutic beneficial effect on metabolic syndrome (increased body weight, hepatic steatosis, insulin resistance and hypertension) in mice. A recent article which was published in nature medicine by Lee and colleagues1 on

Metabolic Syndrome, also known as Syndrome X and insulin resistance syndrome, is becoming increasingly prevalent in our country. To be diagnosed with Metabolic Syndrome, an individual must have three of the five conditions that constitute this syndrome. The conditions are hyperlipidemia, hypertension, high fasting blood glucose levels, as well as a large waistline, or obesity. These five conditions are interrelated and play significant roles in the formation of Metabolic Syndrome, which increases

Metabolic syndrome (MetS) is a complex condition that comprises of at least three of five of the following medical conditions: abdominal or central obesity, elevated blood pressure (HBP), elevated fasting plasma glucose (FPG), high serum triglycerides (TG) and low high density lipoprotein (HDL) levels[1]. Metabolic syndrome is also commonly known as Syndrome X, insulin resistance syndrome (IRS) and Reaven's syndrome (named after Gerald Reaven). MetS has been defined by many organizations such as

Metabolic syndrome is a group of disorders that associated with high blood pressure, increased blood sugar, abnormal adipose deposition, and abnormal cholesterol or triglyceride levels. It is clear that with increasing rates of obesity the disease can begin at different ages and can extremely increase in childhood and adolescent. One of the most important complications of metabolic syndrome is cardiovascular disorders (CVDs). The latest report of the World Health Organization has shown that cardiovascular

The metabolic syndrome is a cluster of the most dangerous heart attack risk factors: diabetes and raised fasting plasma glucose, abdominal obesity, high cholesterol and high blood pressure. Metabolic syndrome often precedes the onset of T2D and cardiovascular diseases (10, 11). Worldwide, it has been estimated that approximately one-fourth of the adult population has metabolic syndrome (10) and that the joined burden of obesity related diseases causes 2.8 million deaths annually (1). There are 10

Introduction The Metabolic Syndrome (MS) is a collection of various core metabolic dysfunctions and problems. These include central obesity, insulin resistance, hypertension, and dyslipidemia. Together these create a syndrome that is associated with obesity and diabetes among other diseases (Bertrais et al., 2005). The etiology of MS is varied and as such, diet and inactivity are proposed risk factors explaining the progression to the Metabolic Syndrome. Their effects on central obesity, hypertension

Metabolic syndrome is not a disease itself, it's made up of multiple diseases, which means it has many causes. The usual risk factors are, obesity and an unhealthy lifestyle, but it can also be caused by insulin resistance and hormonal imbalance. Insulin resistance is a common link to metabolic syndrome because it has much to do with metabolism, which is when the body produces digested food into energy. Insulin helps cells throughout the body take glucose and use it for energy. With insulin resistance

Metabolic Syndrome The clinical significance of metabolic syndrome (MS) is well defined and described since the 1920’s. The general conditions defines MS, and are part of the equation to determine the results from the National Cholesterol Education Program Adult Treatment Panel (NCEP/ATP III) definition and from the Centers for Disease Control (Center for Disease Control and Prevention, 2013). Based on the National Health and Nutrition Examination Survey 1999 - 2014 (NHANES) report, there was

Liver is known as the metabolic port of entry for any endobiotic and xenobiotic substance. The anabolism and catabolism of most of the nutrients are in major performed by the liver. Carbohydrate, protein and fat metabolism by the liver is of significance as the anomalies in metabolism of these nutrients may introduce several types of metabolic syndromes. The protective effects of aqueous green tea extract have been shown on hyperglycaemia, hyperlipidaemia and liver dysfunction in diabetic and obese